Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type

Anti-SARS-CoV-2 Revaccination Success in Kidney Transplant Recipients With No Initial Humoral Response Is Linked to Primary Vaccine Type

BackgroundWhile anti-SARS-CoV-2 vaccination success in kidney transplant recipients (KTR) after two doses and 1273-mRNA was associated with higher seroconversion rates compared to BNT162b2-mRNA in our “DIA-Vacc Study” (NCT04799808), it remains unclear whether this may also be the case in non-respond...

Full description

Bibliographic Details
Main Authors: Julian Stumpf, Jörg Schwöbel, Claudia Karger, Holger Schirutschke, René Mauer, Anna Klimova, Torsten Tonn, Christian Hugo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Medicine
Subjects:
revaccination
kidney transplant recipient (KTR)
SARS-CoV-2
humoral response
1273-mRNA
BNT162b2-mRNA
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2022.910987/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2022.910987/full

Similar Items